Review: Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
The Collaboration on Severe Asthma (COSA) is a global platform for the exchange of scientific and clinical information on severe asthma to better understand the complexities of the disease and continually improve strategies for optimal care of the severe asthma patient. COSA initiatives, organized by the World Allergy Organization, currently include live symposia, online learning programs, scientific journal articles and online resource sharing.
In these pages you can search a growing database of scientific article references that are related to severe asthma and link out to the abstracts and articles that are available online.
Several educational resources on severe asthma are available with the World Allergy Organization online, and you can find a searchable list here.
You can also view where the Collaboration on Severe Asthma will be presenting new information as well as past activities here.
To view COSA members, click here.
NEW! Asthma Briefs on WAO TV
What Is Severe Asthma? Why Is It Important? Eugene R. Bleecker, MD Watch Video
Precision Medicine as It Relates to Severe Asthma Sally E. Wenzel, MD Watch Video
Blood Eosinophils in Severe Asthma David B. Price, MD Watch Video
Severe Asthma in Developing Countries Alvaro A. Cruz, MD Watch Video
Asthma COPD Overlap Syndrome (ACOS) Maarten van den Berge, MD, PhD Watch Video
Upcoming Activities of the Working Group
WAO International Scientific Conference (WISC 2016) Jerusalem
COSA Symposium: Severe Asthma
Thursday, 8 December 2016
11:00 AM to 12:30 PM